FDA official logo
GSRS logo
PFDA official logo

OFATUMUMAB

  • UNII: M95KG522R0
  • Preferred Substance Name: OFATUMUMAB

  • 679818-59-8
  • 2F2
  • ARZERRA
  • GSK1841157
  • GSK-1841157
  • GSKI841157
  • HUMAX-CD20
  • HUMAX-CD20 2F2
  • HUMAX-CD20, 2F2
  • HUMAX-CD20-2F2
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
  • OFATUMUMAB [EMA EPAR]
  • OFATUMUMAB [INN]
  • OFATUMUMAB [JAN]
  • OFATUMUMAB [MART.]
  • OFATUMUMAB [MI]
  • OFATUMUMAB [PURPLE BOOK CDER]
  • OFATUMUMAB [USAN]
  • OFATUMUMAB [VANDF]
  • OFATUMUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.